137
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Elevated circulating magnesium levels in patients with Parkinson’s disease: a meta-analysis

, , , &
Pages 3159-3168 | Published online: 19 Nov 2018

References

  • LeesAJHardyJReveszTParkinson’s diseaseLancet200937396802055206619524782
  • de LauLMGiesbergenPCde RijkMCHofmanAKoudstaalPJBretelerMMIncidence of parkinsonism and Parkinson disease in a general population: the Rotterdam StudyNeurology20046371240124415477545
  • SveinbjornsdottirSThe clinical symptoms of Parkinson’s diseaseJ Neurochem2016139Suppl 131832427401947
  • PowersKMSmith-WellerTFranklinGMLongstrethWTSwansonPDCheckowayHParkinson’s disease risks associated with dietary iron, manganese, and other nutrient intakesNeurology200360111761176612796527
  • BettiolSSRoseTCHughesCJSmithLAAlcohol consumption and Parkinson’s disease risk: a review of recent findingsJ Parkinsons Dis20155342544226406123
  • OhCKSultanAPlatzerJS-Nitrosylation of PINK1 attenuates PINK1/Parkin-dependent mitophagy in hiPSC-based Parkinson’s disease modelsCell Rep20172182171218229166608
  • GuoYBChenJZhangXDXuSBLiuHYMolecular dynamics simulations to understand LRKK2 mutations in ParkinsonMol Simul20164216470
  • PapagiannakisNKorosCStamelouMAlpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson’s DiseaseNeurosci Lett20186721314514929129675
  • SinglaNDhawanDKInfluence of zinc on calcium-dependent signal transduction pathways during aluminium-induced neurodegenerationMol Neurobiol201450261362524500000
  • WenHQinYZhongWLiCLiuXShenYTrivalent metal ions based on inorganic compounds with in vitro inhibitory activity of matrix metalloproteinase 13Enzyme Microb Technol20169291727542739
  • AizenmanEMastroberardinoPGMetals and neurodegenerationNeurobiol Dis2015811326542885
  • LangleyMRGhaisasSAyMManganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson’s disease: relevance to gene and environment interactions in metal neurotoxicityNeurotoxicology20186424025528595911
  • MedeirosMSSchumacher-SchuhACardosoAMIron and oxidative stress in Parkinson’s disease: an observational study of injury biomarkersPLoS One2016111e014612926751079
  • WangXMouallaDWrightJABrownDRCopper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicityJ Neurochem2010113370471420141569
  • LiYSunLCaiTAlpha-Synuclein overexpression during manganese-induced apoptosis in SH-SY5Y neuroblastoma cellsBrain Res Bull2010814–542843319932157
  • GrubbsRDMaguireMEMagnesium as a regulatory cation: criteria and evaluationMagnesium1987631131273306178
  • LairesMJMonteiroCPBichoMRole of cellular magnesium in health and human diseaseFront Biosci2004926227614766364
  • SwaminathanRMagnesium metabolism and its disordersClin Biochem Rev2003242476618568054
  • ShindoYYamanakaRSuzukiKHottaKOkaKIntracellular magnesium level determines cell viability in the MPP(+) model of Parkinson’s diseaseBiochim Biophys Acta20151853123182319126319097
  • OyanagiKKawakamiEKikuchi-HorieKMagnesium deficiency over generations in rats with special references to the pathogenesis of the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of GuamNeuropathology200626211512816708544
  • BarbeauAJasminGDuchastelYBiochemistry of Parkinson’s diseaseNeurology196313565813966496
  • GelleinKSyversenTSteinnesETrace elements in serum from patients with Parkinson’s disease – a prospective case-control study: the Nord-Trøndelag Health Study (HUNT)Brain Res2008121911111518538747
  • AlimontiARistoriGGiubileiFSerum chemical elements and oxidative status in Alzheimer’s disease, Parkinson disease and multiple sclerosisNeurotoxicology200728345045617267042
  • ForteGBoccaBSenofonteOTrace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson’s diseaseJ Neural Transm200411181031104015254791
  • ForteGAlimontiAPinoAMetals and oxidative stress in patients with Parkinson’s diseaseAnn Ist Super Sanita200541218919516244392
  • BoccaBAlimontiASenofonteOMetal changes in CSF and peripheral compartments of parkinsonian patientsJ Neurol Sci20062481–2233016765382
  • MaassFMichalkeBLehaAElemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson’s diseaseJ Neurochem2018145434235129388213
  • SchwabRSPoryaliAAmesANormal serum magnesium levels in Parkinson’s diseaseNeurology19641485585614215602
  • SanyalJAhmedSSNgHKMetallomic biomarkers in cerebrospinal fluid and serum in patients with Parkinson’s disease in Indian populationSci Rep201663509727752066
  • MoherDLiberatiATetzlaffJAltmanDGPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementInt J Surg20108533634120171303
  • GreenSMcDonaldSCochrane Collaboration: more than systematic reviews?Intern Med J20053513515667459
  • HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
  • SongFGilbodySBias in meta-analysis detected by a simple, graphical test. Increase in studies of publication bias coincided with increasing use of meta-analysisBMJ19983167129471
  • HigginsJPThompsonSGControlling the risk of spurious findings from meta-regressionStat Med200423111663168215160401
  • TobiasAAssessing the in fluence of a single study in the meta-analysis estimateStata Tech Bull19998471517
  • DuvalSTweedieRTrim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysisBiometrics200056245546310877304
  • SunYSukumaranPSchaarASinghBBTRPM7 and its role in neurodegenerative diseasesChannels20159525326126218331
  • KolisekMNestlerAVormannJSchweigel-RöntgenMHuman gene SLC41A1 encodes for the Na+/Mg2+ exchangerAm J Physiol Cell Physiol20123021C318C32622031603
  • KolisekMZsurkaGSamajJWeghuberJSchweyenRJSchweigelMMrs2p is an essential component of the major electrophoreticMg2+ influx system in mitochondriaEMBO J20032261235124412628916
  • KolisekMMontezanoACSponderGPARK7/DJ-1 dysregulation by oxidative stress leads to magnesium deficiency: implications in degenerative and chronic diseasesClin Sci2015129121143115026453619
  • CookNLvan den HeuvelCVinkRCharacterisation of TRPM channel mRNA levels in Parkinson diseaseMagnes Res2009223188189
  • TucciANallsMAHouldenHGenetic variability at the PARK16 locusEur J Hum Genet201018121356135920683486
  • KolisekMSponderGMastrototaroLSubstitution p.A350V in Na+/Mg2+ exchanger SLC41A1, potentially associated with Parkinson’s disease, is a gain-of-function mutationPLoS One201388e7109623976986
  • BarbiroliBIottiSCortelliPLow brain intracellular free magnesium in mitochondrial cytopathiesJ Cereb Blood Flow Metab199919552853210326720
  • JimersonDCPostRMCarmanJSCSF calcium: clinical correlates in affective illness and schizophreniaBiol Psychiatry19791413751420907
  • LevineJSteinDRapoportAKurtzmanLHigh serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patientsNeuropsychobiology1999392637010072661
  • HoyerWAntonyTChernyDHeimGJovinTMSubramaniamVDependence of alpha-synuclein aggregate morphology on solution conditionsJ Mol Biol2002322238339312217698
  • LoweRPountneyDLJensenPHGaiWPVoelckerNHCalcium(II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domainProtein Sci200413123245325215537754
  • ZhangQSHengYYuanYHChenNHPathological α-synuclein exacerbates the progression of Parkinson’s disease through microglial activationToxicol Lett2017265303727865851
  • LuoPYZhuXZhangYPDetermination of serum trace elements levels and CT scans of brain in Parkinson’s diseaseActa Univ Med Second Shanghai198774332334
  • HegdeMLShanmugaveluPVengammaBSerum trace element levels and the complexity of inter-element relations in patients with Parkinson’s diseaseJ Trace Elem Med Biol200418216317115646263
  • Sanjay PandeMBNagabhushanPHegdeMLRaoTSRaoKSAn algorithmic approach to understand trace elemental homeostasis in serum samples of Parkinson diseaseComput Biol Med200535647549315780860
  • AhmedSSSantoshWMetallomic profiling and linkage map analysis of early Parkinson’s disease: a new insight to aluminum marker for the possible diagnosisPLoS One201056e1125220582167
  • OgunrinAOKomolafeMASanyaEOTrace metals in patients with Parkinson’s disease: a multi-center case-control study of Nigerian patientsJ Neurol Epidemiol2013113138
  • FengJYangXLMaQPWangYLYaoYNThe case-control study on relationship between blood metal elements and Parkinson disease in Uygur of Hetian region in XinjiangJ Xinjiang Med Univ2012353342345
  • AlimontiABoccaBPinoARuggieriFForteGSancesarioGElemental profile of cerebrospinal fluid in patients with Parkinson’s diseaseJ Trace Elem Med Biol200721423424117980814
  • HozumiIHasegawaTHondaAPatterns of levels of biological metals in CSF differ among neurodegenerative diseasesJ Neurol Sci20113031–2959921292280